Immunonutrition in Ulcerative Colitis
Recruiting in Palo Alto (17 mi)
Overseen byRandal K Buddington, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Baptist Memorial Health Care Corporation
Trial Summary
What is the purpose of this trial?
This study tests the hypothesis that a supplement that combines a functional fiber, long chain omega-3 polyunsaturated fatty acids (PUFAs), vitamin D3, vitamin E, and zinc will reduce clinical symptoms, decrease pro-inflammatory cytokines in the blood and ergo decrease inflammation, promote beneficial microbial activity in the colon, and help recovery of the intestinal mucosa of ulcerative colitis (UC) patients compared with a placebo.
Eligibility Criteria
Inclusion Criteria
patients with active ulcerative colitis (proof of diagnosis from gastroenterologist), over 18 years old, has over 50% gut remaining, fully connected bowels (no colostomy), currently on 5-aminosalicylates (ASA) drugs, not pregnant or lactating
Treatment Details
Interventions
- Nutrition supplement (Dietary Supplement)
- Placebo supplement (Placebo)
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: SupplementActive Control1 Intervention
active supplement consisting of a fermentable fiber, omega-3 polyunsaturated fatty acid, vitamin D3, vitamin E, and zinc
Group II: PlaceboPlacebo Group1 Intervention
placebo consisting of rice starch, light olive oil, and vegetable oil
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
GI Specialists FoundationMemphis, TN
Loading ...
Who Is Running the Clinical Trial?
Baptist Memorial Health Care CorporationLead Sponsor